Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 11 to 20 of 455 resources
-
Shooting Up: infections and other injecting-related harms among people who inject drugs in the UK, 2023 update
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom. This report is an update issued in March 2023 and includes the most recent data, which covers the period up to the end of 2021.UK 22 Mar 2023 Reports & Research PDF -
Taking the initiative: how England is eliminating hepatitis C
This report explores the unprecedented hepatitis C elimination programme developed since 2019 between NHS England, pharmaceutical industry providers, voluntary sector bodies and other partners, and profiles ‘elimination initiatives’ that have been developed in different parts of the country and wider health and care system as a result.England 21 Feb 2023 Reports & Research PDF -
Hepatitis C in the UK 2023: Working to eliminate hepatitis C as a public health threat
UKHSA has published its report ‘Hepatitis C in the UK 2023: Working to eliminate hepatitis C as a public health threat’. The report reviews the progress that has been made towards the WHO target of eliminating hepatitis C by 2030, and is based on data up to the end of 2021.UK, England, Northern Ireland, Scotland, Wales 03 Feb 2023 Reports & Research PDF -
HCV Action webinar summary report – Hepatitis C elimination initiatives: an overview
This webinar, which took place in December 2022, was organised by HCV Action in order to provide an overview of the NHS England hepatitis C 'elimination deal' and the activity that has taken place as part of it. The audience was primarily people who wished to have a more comprehensive understanding of the elimination deal and the various initiatives it launched to identify and treat undiagnosed patients. This summary report provides an overview of the key points from each of the webinar speakers.England 23 Jan 2023 Reports & Research, Strategy & Planning PDF -
Good practice case study: Targeted HCV testing in Bristol Emergency Department
The aim of the Emergency Department Peer Support Lead project is to improve the uptake of HCV testing in at-risk patients attending Bristol Royal Infirmary ED, using point-of-care testing on-site, conducted by the Hepatitis C Trust peer support worker and supported by the BRI hepatology team to provide treatment for any HCV-RNA positive patient identified within four weeks of a positive test.UK, England, South West 12 Jan 2023 Case study PDF -
Emergency department opt out testing for HIV, hepatitis B and hepatitis C: The first 100 days
This report from NHS England sets out learnings and results from the first 100 days of the emergency department opt out testing for HIV, hepatitis B and hepatitis C programme.England 29 Nov 2022 Reports & Research PDF -
Surveillance of hepatitis C in Scotland
This Public Health Scotland report provides an update on progress towards elimination of hepatitis C as a major public health concern in Scotland. The surveillance data suggests there has been major progress made on a number of hepatitis C elimination targets in Scotland.Scotland 08 Nov 2022 Reports & Research PDF -
ODN Event 2022: Nurse perspective
The fifth talk of the day at the HCV Action Hepatitis C ODN Stakeholder Event 2022, this is a focus on the nurse perspective. Delivered by Helen Caldwell, a Hepatology Nurse Consultant at the Royal Liverpool and Broadgreen University Hospital NHS Trust.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Elimination programme updates – Gilead Sciences
The sixth presentation of the day at October's HCV Action Hepatitis C ODN Stakeholder Event 2022, an update on the elimination programme from Gilead Sciences. Delivered by Dr William McCully, Patient Access to Care Director at Gilead Sciences, and Tracey Kemp, National Hepatitis C Strategy Lead, at CGL.England 31 Oct 2022 Reports & Research, Strategy & Planning Video -
ODN Event 2022: Elimination programme updates - MSD
The seventh and penultimate talk of the HCV Action Hepatitis C ODN Stakeholder Event 2022, an update from MSD on the elimination programme. Given by Kuldip Sembhi, HCV Elimination Programme Lead at MSD, and Ray Cottington, Community Liaison Officer at University Hospitals of Leicester NHS Trust.England 31 Oct 2022 Reports & Research, Strategy & Planning Video